Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian Cancer

@inproceedings{Wang2011EnhancingCR,
  title={Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian
                    Cancer},
  author={Enfeng Wang and Sanjib Bhattacharyya and Annam{\'a}ria Szabolcs and Cristian Rodriguez-Aguayo and Nicholas B. Jennings and Gabriel L{\'o}pez-Berestein and Priyabrata Mukherjee and Anil Sood and Resham Bhattacharya},
  booktitle={PloS one},
  year={2011}
}
Undoubtedly ovarian cancer is a vexing, incurable disease for patients with recurrent cancer and therapeutic options are limited. Although the polycomb group gene, Bmi-1 that regulates the self-renewal of normal stem and progenitor cells has been implicated in the pathogenesis of many human malignancies, yet a role for Bmi-1 in influencing chemotherapy response has not been addressed before. Here we demonstrate that silencing Bmi-1 reduces intracellular GSH levels and thereby sensitizes… CONTINUE READING
Highly Cited
This paper has 517 citations. REVIEW CITATIONS

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 37 extracted citations

517 Citations

050100150'12'14'16'18
Citations per Year
Semantic Scholar estimates that this publication has 517 citations based on the available data.

See our FAQ for additional information.

References

Publications referenced by this paper.
Showing 1-10 of 51 references

The polycomb group gene Bmi1 regulates antioxidant defenses in neurons by repressing p53 pro-oxidant activity.

The Journal of neuroscience : the official journal of the Society for Neuroscience • 2009
View 4 Excerpts
Highly Influenced

Therapeutic Targeting of ATP7B in Ovarian Carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2009
View 4 Excerpts

Similar Papers

Loading similar papers…